Trial
NCT00276861
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Colorectal Cancer
Intervention
gemcitabine hydrochloride
Why stopped
Low Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-08